Third, although LXRβ agonists and antagonists were core intervention methods to our investigation of glial and cortical function regulation, FCD involves multiple molecular pathways, including mTOR, TSC1/2, PI3K/Akt and so on. The gene discussed is TSC1; the disease is fleck corneal dystrophy.